Resource Center
Always with a focus on innovation, find resources that share our scientific experts passion and knowledge. Find case studies, info sheets, posters and more.
De-Risking FIH: Integrated Strategies for Rapid Proof-of-Concept
Download13 - 18 of 232 results
On-Demand: From First-In-Human To Proof-Of-Concept — Quicker, Smarter, Streamlined
14 October 2025Taste Assessment Study of Bivamelagon (MC72) Paediatric Solution Formulations
8 October 2025Formulation Optimization of EVX-101, A Novel Gastro-Retentive Prolonged-Release 5-HTP/Low-Dose Carbidopa Tablet
8 October 2025Development of an Extended Release Nafamostat Formulation for Prescription Drug Overdose Protection
8 October 2025A First-in-Human Assessment for TQS-168, Including Safety, Tolerability, Pharmacokinetics, Formulation Selection, and Food effect in healthy volunteers
8 October 2025Quotient Sciences 2024 ESG Report
19 September 2025Learn about Quotient Sciences' services
Where integrated CRDMO services bring therapies to life. Whether it's meeting your first-in-human milestone, confidently advancing your program to proof-of-concept, or providing a trusted supply of clinical trial materials or commercial drug product, learn about Quotient Sciences CRDMO offering and how we can support your next drug program.